TheraRadar
← Back
Data updated: Mar 29, 2026

IMP

NeurologyOncologyRespiratory
Pharma

IMP is a pharmaceutical company focused on Neurology, Oncology, Respiratory.

1987
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 45%
0 drugs Phase 3: 4 Phase 2: 5 Phase 1: 2
Oncology 34%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 15
Respiratory 13%
0 drugs Phase 3: 1 Phase 2: 2
Cardiovascular 6%
0 drugs Phase 1: 4
Gastroenterology 2%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Oncology, Cardiovascular, Respiratory
GE HEALTHCARE specialty
Neurology, Cardiovascular, Oncology, Respiratory
GSK big-pharma
Respiratory, Oncology, Neurology
Roche big-pharma
Oncology, Neurology, Respiratory
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Neurology